About
Technology
Issues
FAQ
Links
Official Page
Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
